On February 8, 2021, FDA released a list of clinical field studies that are underway to investigate stem cells and other regenerative therapies in veterinary patients. FDA released this list to help pet owners and their veterinary teams connect with relevant clinical studies, and to help sponsors generate data for new veterinary drug applications.
FDA regulates regenerative medicine products for animals with tendon injuries, osteoarthritis, and fertility issues, among other conditions. Field trials currently under way include:
- a field trial for stem cell therapy in English bulldogs with spina bifida;
- a field trial for stem cell therapy in cats with chronic enteropathy (malabsorption of nutrients; and
- a field trial for stem cell therapy in cats with chronic gingivostomatitis (severe gum inflammation).
FDA intends to update the list as new field trials come on line.
thelawoflifesciences.com 